期刊文献+

多囊卵巢综合征患者代谢综合征指标分析 被引量:4

Clinical analysis of the indicators for metabolic syndrome in patients with polycystic ovary syndrome
原文传递
导出
摘要 目的探讨多囊卵巢综合征(PCOS)患者代谢综合征(MetS)及其组分的发生特点,评估MetS组分对PCOS患者罹患MetS发生风险的预测能力。方法选择2008年9月至2012年4月在福建省妇幼保健院妇科门诊诊断为PCOS患者208例及随机招募的体检者205例。PCOS诊断标准参照鹿特丹标准,MetS诊断标准依据国际糖尿病联盟(IDF)颁布的定义。所有受试者均进行人体测量和生化指标测定,比较两组MetS及其组分的发生特点,筛选对PCOS患者罹患MetS发生风险的预测指标。结果 208例PCOS患者MetS发生率为21.15%,明显高于对照组3.41%。具有1项及以上MetS组成成分的PCOS患者高达69.23%;血脂异常是主要的代谢紊乱,其次是高血压、空腹血糖异常。腰围(WC)结合高密度脂蛋白胆固醇(HDL-C)或腰围(WC)结合三酰甘油(TG)具有对PCOS患者发生MetS风险较高的预测能力。结论对于WC≥80cm的PCOS患者,一旦具备HDL-C<1.29mmol/L或TG>1.7mmol/L就应对其进行预防MetS发生的早期干预。 Objective To compare the prevalence of metabolic syndrome (MetS) and its abnormal components in poly- cystic ovary syndrome (PCOS) women, and analyze the ability of MetS components to predict MetS risk in PCOS patients. Methods A total of 208 PCOS women participated in this study between September 2008 and April 2012. The control group was comprised of 205 women recruited randomly. The analysis was done with PCOS patients who were diagnosed u- sing Rotterdam 2003 criteria. The MetS diagnostic criteria of the International Diabetes Federation (IDF) was used. All of the subjects were examined for anthropometric and biochemical parameters. We compared the incidence of MetS and its components between the two groups, and analyzed the ability of MetS components to predict MetS risk in PCOS patients. Results The prevalence of MetS in PCOS patients was 21.15% significantly higher than controls. PCOS patients with one or more MetS components were up to 69. 23%. Dyslipidemia was the most important feature of metabolic disorders, subsequently hypertension and impaired fasting glucose. WC coupled with HDL-C or WC coupled with TG gave relatively good predictions of the risk of MetS in Chinese patients with PCOS. Conclusion The early intervention to prevent the oc- currence of MetS was required for PCOS patients with WC ~〉 80 cm once dyslipidemia ( HDL-C 〈 1.29 mmol/L or TG 〉 1.7mmol/L) occurred.
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2013年第3期192-196,共5页 Chinese Journal of Practical Gynecology and Obstetrics
基金 卫生部科学研究基金资助项目(WKJ2008-2-58) 福建省临床重点专科建设项目资助(闽财指20121589号)
关键词 多囊卵巢综合征 代谢综合征 血脂异常 polycystic ovarian syndrome metabolic syndrome dyslipidemia
  • 相关文献

参考文献10

  • 1Rocha MP, Marcondes JA, Barcellos CR, et al. Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors[ J]. Gynecol Endocrino1,2011,27 ( 10 ) : 814-$19.
  • 2Legro RS. Polycystic ovary syndrome and cardiovascular disease : a premature association? [ J ]. Endocr Rev, 2003,24 ( 3 ) : 302- 312.
  • 3Goverde AJ, van Koert AJ, Eijkemans MJ, et al. Indicators for metabolic disturbances in anovulatory women with polycystic o- vary syndrome diagnosed according to the Rotterdam consensus criteria[J]. Hum Reprod,2009,24(3) : 710-717.
  • 4Daskalopoulos GN, Karkanaki A, Karagiannis A, et al. Is the risk for cardiovascular disease increased in all phenotypes of the polycystic ovary syndrome ? [ J ]. Angiology, 2011,62 ( 4 ) : 285- 290.
  • 5Shannon M,Wang Y. Polycystic ovary syndrome: a common but often unrecognized condition [ J ]. J Midwifery Womens Health, 2012,57(3) : 221-230.
  • 6Redondo S, Mart nez-Gonz lez J, Urraca C, et al. Emerging thera- peutic strategies to enhance HDL function [ J ]. Lipids Health Dis,2011,10: 175.
  • 7Dokras A, Bochner M, Hollinrake E, et al. Screening women with polycystic ovary syndrome for metabolic syndrome [ J ]. Obstet Gynecol,2005,106( 1 ) : 131-137.
  • 8Hahn S, Tan S, Elsenbruch S, et al. Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia[ J ]. Horm Metab Res, 2005,37 ( 7 ) : 438 ..44.
  • 9胡卫红,乔杰,王黎娜,同军.多囊卵巢综合征患者代谢综合征的发生及临床特征的相关性[J].北京大学学报(医学版),2010,42(2):159-163. 被引量:50
  • 10Gambineri A, Repaci A, Patton L, et al. Prominent role of low HDL- cholesterol in explaining the high prevalence of the meta- bolic syndrome in polycystic ovary syndrome [ J ]. Nutr Metab Cardiovasc Dis,2009,19( 11 ) : 797-804.

二级参考文献16

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3089
  • 2李岩,赵冬,王薇,王文化,孙佳艺,秦兰萍,贾妍娜,吴兆苏.中国11省市35~64岁人群应用不同代谢综合征诊断标准的比较[J].中华流行病学杂志,2007,28(1):83-87. 被引量:89
  • 3Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J].Fertil Steril,2004,81(1):19-22.
  • 4Katz A,Nambi SS,Mather K,et al.Quantitative insulin sensitivity check index:A simple,accurate method for assessing insulin sensitivity in hunams[J].J Clin Endocrinol Metab,2000,85(7):2402-2410.
  • 5Glueck CJ,Papanna R,Wang P,et al.Incidenceand treatment of metabolic syndrome in newly referred women with confirned polycystic ovarian syndrome[J].Metabolism,2003,52(7):908-915.
  • 6Apridonidze T,Essah PA,Iuorno MJ,et al.Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome[J].J Clin Endocrinol Metab,2005,90(4):1929-1935.
  • 7Essah PA,Nestler JE.Metabolic syndrome in women with polycystic ovary syndrome[J].Fertil Steril,2006,86(Suppl 1):S18-19.
  • 8soares EMM,Azevedo GD,Gadelha RGN,et al.Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome[J].Fertil Steril,2008,89(3):649-655.
  • 9Carmina E,Napoli N,Longo RA,et al.Metabolic syndrome in polycysfic ovary syndrome(PCOS):Lower prevalence in southern Italy than in the USA and influence of criteria for the diagnosis of PCOS[J].Euro J Endocrinol,2006,154(1):141-145.
  • 10Vrbiková J,Vondra K,Cibula D,et al.Metabolic syndrome in young Czech women with polycystic ovary syndrome[J].Hum Reprod,2005,20(12):3328-3332.

共引文献49

同被引文献31

  • 1游凯.多囊卵巢综合征患者的血脂异常及其处理要点[J].中华妇产科杂志,2007,42(10):716-718. 被引量:7
  • 2Fauser B C, Tarlatzis B C, Rebar R W, et al. Consensus on women's health aspects of polycystic ovary syndrome( P- COS): the Amsterdam ESHRE/ASRM-Sponsored 3rd P- COS Consensus Workshop Group[ J]. Fertil Steril, 2012, 97( 1 ) :28-38.
  • 3Coviello A D, Legro R S, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the met- abolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance [ J ]. J Clin Endocrinol Metab, 2006,91 (2) :492-497.
  • 4Vrbikova J, Vondra K, Cibula D, et al. Metabolic syn- drome in young Czech women with polycystic ovary syn- drome [ J ]. Hum Reprod, 2005,20 (12) :3328- 3332.
  • 5Glueek C J, Papanna R, Wang P, et al. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome [ J ]. Metabo- lism, 2003,52(7) :908-915.
  • 6Li R, Yu G, Yang D, et al. Prevalence and predictors of metabolic abnormalities in Chinese women with PCOS: a cross-sectional study [ J ]. BMC Endocr Disord, 2014, 14 : 76.
  • 7Soares E M, Azevedo G D, Gadelha R G, et al. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome [ J ]. Fertil Steril, 2008,89 (3) :649-655.
  • 8Weerakiet S, Bunnag P, Phakdeekitcharoen B, et al. Prev- alence of the metabolic syndrome in Asian women with poly- cystic ovary syndrome: using the International Diabetes Federation criteria[ J ]. Gynecol Endocrinol, 2007,23 ( 3 ) : 153-160.
  • 9Marcondes J A, Hayashida S A, Barcellos C R, et al. Met-abolic syndrome in women with polycystic ovary syndrome: prevalence, characteristics and predictors [ J ]. Arq Bras Endocrinol Metabol, 2007,51 (6) :972-979.
  • 10Ehrmann D A, Liljenquist D R, Kasza K, et al. Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome [ J ]. J Clin Endocrinol Metab, 2006,91 ( 1 ) :48-53.

引证文献4

二级引证文献87

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部